G Medical Innovations Holdings Ltd (GMVD) Return on Assets ROA from the fourth quarter of 2022 to fourth quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
G Medical Innovations Holdings Ltd   (NASDAQ: GMVD)


G Medical Innovations Holdings Ltd 's ROA from the fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is G Medical Innovations Holdings Ltd 's ROA in the fourth quarter of 2022?
G Medical Innovations Holdings Ltd achieved a return on average assets (ROA) of 418.92 % in its fourth quarter of 2022, this is above GMVD's average return on assets of -519.5%.
G Medical Innovations Holdings Ltd assets over the 12 months ending in its fourth quarter of 2022 are valued at $6 million

ROA has improved compared to 201.01% in the third quarter of 2022, due to net income growth.

However, within the Healthcare sector 1256 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2022 from to 6398.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2022)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Total Assets Change -54.12 % -54.12 % -69.99 % -54.12 % 179.11 %
Y / Y Net Income Change 68.36 % - - - -
Net Income (TTM) in million 25 15 15 15 15
Return On Assets (TTM) 418.92 % 201.01 % 168.62 % 103.78 % 94.42 %
GMVD's Total Ranking # 6398 # # # #
Total Assets (TTM) in million 5 5 9 5 11
Seq. Total Assets Change 0 % -48.99 % 96.04 % -54.12 % 0 %
Seq. Net Income Change - - - - -

GMVD's 5 Years Annual ROA >> Back to GMVD Management Effectiveness >> Compare GMVD ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 265
Sector # 1257
Overall # 6178

Return On Assets Statistics
High Average Low
-519.5 %
-519.5 %
-519.5 %
(Dec 31 2022)  





Financial Statements
G Medical Innovations Holdings Ltd 's Assets $ 5 million GMVD's Balance sheet
G Medical Innovations Holdings Ltd 's Income $ 25 million Quarterly GMVD's Income Statement
GMVD's Income by Division See GMVD's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
FY
FY
FY
Y / Y Total Assets Change -54.12 % - - - -
Total Assets in million 5 11 0 0 0
Y / Y Net Income Change - - - - -
Net Income in million -25 -15 0 0 0
Annual Return On Assets -519.5 % -141.56 % - - -

GMVD's 5 Years Annual ROA >> Back to GMVD Management Effectiveness >> Compare GMVD ROA to its Competitors



More Return On Assets Ratios
GMVD's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
GMVD's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GMVD's Competitors
Subscribers only: Roa for G Medical Innovations Holdings Ltd 's Suppliers
Subscribers only: Return On Assets for GMVD's Customers

You may also want to know
GMVD's Roi GMVD's Inventory Turnover Ratio GMVD's Growth Rates GMVD's Dividend Comparisons
GMVD's Profitability Ratios GMVD's Asset Turnover Ratio GMVD's Dividend Growth
GMVD's Roe GMVD's Valuation Ratios GMVD's Financial Strength Ratios GMVD's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2022, within Healthcare Sector ROA
Inhibitor Therapeutics Inc   402.26 %
Global Innovative Platforms Inc.  286.90 %
Theravance Biopharma inc   167.15 %
Ir med Inc   132.23 %
Gyre Therapeutics Inc   108.86 %
Galmed Pharmaceuticals Ltd   108.09 %
Chimerix Inc   99.48 %
Therapeuticsmd Inc   88.90 %

Date modified: 2023-05-17T17:43:32+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.